Activity of single-agent melphalan 220–300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma
暂无分享，去创建一个
D. Howard | D. Reece | A. Rapoport | R. Fenton | N. Flomenberg | D. Vesole | B. Mookerjee | N. Takebe | B. Meisenberg | K. Marshall | C. Sarkodee-Adoo | G. Phillips | D. Grosso | J. Wagner | V. Adams | J. Brunner | V. Johnson | A. Badros | J. Filicko | G. Hale | A. Kniska | B. Mookerjee | R. Nath | C. Sarkodee‐Adoo | Robert G. Fenton